Prot#CAUY922AUS01T//NU 10L01: A Phase I/II Trial of HSP90 Inhibitor AUY-922 in Patients with Lung Adenocarcinoma with "Acquired Resistance" to EGFR Tyrosine Kinase Inhibitors

Project: Research project

Project Details

StatusFinished
Effective start/end date12/1/10 → 3/31/18

Funding

  • Novartis Pharmaceuticals Corporation (NU 10L01)